Chaim Lebovits | Chief Executive Officer |
Ralph Kern | Chief Medical Officer and Chief Operating Officer |
Jason Kolbert | Maxim |
David Bautz | Zacks Investment Research |
Good day everyone and welcome to the BrainStorm Cell Therapeutics' Third Quarter 2017 Earnings Call.
Just a reminder today’s call is being recorded. And at this time, it’s my pleasure to turn the conference over to Paul [indiscernible]. Please go ahead sir.
Thank you, Laurie, and good morning everyone and thank you for participating in today's third quarter conference call for BrainStorm Cell Therapeutics.